JAK inhibitor Momelotinib mesylate, Purity ≥98%

Synonym: momelotinib Mesylate; CYT387 Mesylate; 1056636-07-7; CYT387 (Mesylate); N-(Cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide; methanesulfonic acid; JAK inhibitor

CAS Number: 1056636-07-7
Compound CID: 78357762

Product Size

1 mg; 5 mg; 10 mg; 25 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Momelotinib mesylate is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK1, JAK2, and JAK3.

Molecular Weight

510.57

Molecular Formula

C₂₄H₂₆N₆O₅S

Targets

JAK1: 11 nM; JAK2: 18 nM; JAK3: 155 nM

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

Momelotinib mesylate can be applied to research inhibition of JAK1 and JAK2 signaling.

Storage

Store at -20ºC.